| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 168,290 | 147,280 | 118,171 | 131,083 | | Cost of Revenue | 76,454 | 67,510 | 53,023 | 86,922 | | | Gross Profit | 91,836 | 79,770 | 65,148 | 44,161 | | | Operating Expenses | | Research Development | 38,432 | 37,039 | 32,764 | 34,700 | | Selling General and Administrative | 32,523 | 29,779 | 25,822 | 28,673 | | Non Recurring | 14,657 | 379 | 1,347 | 1,158,263 | | Others | 2,980 | 3,406 | 3,506 | 3,340 | | | | Total Operating Expenses | 88,592 | 70,603 | 63,439 | 1,224,976 | | | | Operating Income or Loss | 17,549 | 9,167 | 1,709 | (1,180,815) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,998 | 2,460 | 1,195 | (25,057) | | Earnings Before Interest And Taxes | 5,242 | 11,627 | 2,904 | (1,205,872) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 5,242 | 11,627 | 2,904 | (1,205,872) | | Income Tax Expense | (7,040) | 5,396 | 526 | (10,438) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,282 | 6,231 | 2,378 | (1,195,434) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 5,520 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,282 | 6,231 | 2,378 | (1,189,914) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,282 | $6,231 | $2,378 | ($1,189,914) |
|
0.51% Nasdaq 
Income Statement
